Hottest Stories on Wall Street: Dorman Products, Inc., GlaxoSmithKline plc (NYSE:GSK), Rex Energy Corporation (NASDAQ:REXX), PMC-Sierra Inc. (NASDAQ:PMCS)


POSCO (NYSE:PKX) shares increased 0.05% in last trading session and ended the day at $39.92. PKX Gross Margin is 11.30% and its has a return on assets of 0.70%. POSCO (NYSE:PKX) quarterly performance is -16.90%.

South Korean steelmaker POSCO (NYSE:PKX) has announced that it paid 30 billion yen ($250 million) to its Japanese competitor and partner Nippon Steel & Sumitomo Metal Corp. to settle lawsuits over alleged patent infringement and illicit acquisition of manufacturing technology, according to a statement from the Tokyo-based company. In the lawsuits that date from 2012, Nippon Steel accused South Korea’s top steelmaker of using trade secrets acquired illegally.

Dorman Products, Inc. (NASDAQ:DORM) ended the last trading day at $53.15. Company weekly volatility is calculated as 1.84% and price to cash ratio as 28.17. Dorman Products, Inc. (NASDAQ:DORM) showed a weekly performance of 0.78%.

Dorman Products, Inc. (NASDAQ:DORM) announced that Mathias J. Barton, has been appointed to serve as the Company’s Chief Executive Officer. Mr. Barton succeeds Steven L. Berman, who has assumed the role of Executive Chairman. The appointments of Mr. Barton as CEO and Mr. Berman as Executive Chairman represent the next step in the Company’s long-term succession plan. In connection with Mr. Berman’s appointment as Executive Chairman, Paul R. Lederer, the Company’s Lead Director, said, “Under Steven’s leadership, the Company has become a major force in the Automotive Aftermarket and we are pleased that such an impactful industry leader as Steven will continue to serve the Company as its Executive Chairman.

On 12 October, GlaxoSmithKline plc (NYSE:GSK) shares increased 0.40% and was closed at $40.38. GSK EPS growth in last 5 year was -12.20%. GlaxoSmithKline plc (NYSE:GSK) year to date (YTD) performance is -1.58%.

GlaxoSmithKline plc (NYSE:GSK) announced that it new severe-asthma medicine has received a positive opinion from the scientific committee of the European Medicines Agency for use in adults, clearing a key hurdle towards gaining marketing approval in Europe. If approved, the drug, called mepolizumab, would be the first in a new class known as anti-IL5s, and would be taken as a monthly injection on top of standard treatments.

Rex Energy Corporation (NASDAQ:REXX) shares decreased -8.47% in last trading session and ended the day at $2.70. REXX Gross Margin is 45.00% and its has a return on assets of -16.00%. Rex Energy Corporation (NASDAQ:REXX) quarterly performance is -28.19%.

Rex Energy Corporation (NASDAQ:REXX) has received a hold rating for the short term, according to the latest rank of 3 from research firm, Zacks.

PMC-Sierra Inc. (NASDAQ:PMCS) caters to the Technology space. It has a net profit margin of 0.70% and weekly performance is 34.46%. On the last day of trading company shares ended up at $10.34. PMC-Sierra Inc. (NASDAQ:PMCS) distance from 50-
day simple moving average (SMA50) is 53.40%.

Skyworks Solutions Inc., agreed to buy PMC-Sierra Inc. (NASDAQ:PMCS) for $2 billion in cash, marking the second multibillion-dollar chip merger announced in the past month. PMC shareholders will get $10.50 a share, a 37 percent premium to Monday’s close of $7.69 on the Nasdaq. The deal will add 75 cents a share to Skyworks’ earnings on an annual non-GAAP basis, it said in a statement.


Leave a Reply

Your email address will not be published. Required fields are marked *